Advanced search
1 file | 272.97 KB Add to list

Beyond genes : re-identifiability of proteomic data and its implications for personalized medicine

(2019) GENES. 10(9).
Author
Organization
Abstract
The increasing availability of high throughput proteomics data provides us with opportunities as well as posing new ethical challenges regarding data privacy and re-identifiability of participants. Moreover, the fact that proteomics represents a level between the genotype and the phenotype further exacerbates the situation, introducing dilemmas related to publicly available data, anonymization, ownership of information and incidental findings. In this paper, we try to differentiate proteomics from genomics data and cover the ethical challenges related to proteomics data sharing. Finally, we give an overview of the proposed solutions and the outlook for future studies.
Keywords
proteomics, re-identifiability, privacy, genomics, data, personal medicine, VARIANT PEPTIDES, PROTEIN, IDENTIFICATION, PIPELINE, QUANTIFICATION, DISCOVERY, NEXTPROT, CANCER

Downloads

  • Beyond genes.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 272.97 KB

Citation

Please use this url to cite or link to this publication:

MLA
Boonen, Kurt, et al. “Beyond Genes : Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.” GENES, vol. 10, no. 9, 2019.
APA
Boonen, K., Hens, K., Menschaert, G., Baggerman, G., Valkenborg, D., & Ertaylan, G. (2019). Beyond genes : re-identifiability of proteomic data and its implications for personalized medicine. GENES, 10(9).
Chicago author-date
Boonen, Kurt, Kristien Hens, Gerben Menschaert, Geert Baggerman, Dirk Valkenborg, and Gokhan Ertaylan. 2019. “Beyond Genes : Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.” GENES 10 (9).
Chicago author-date (all authors)
Boonen, Kurt, Kristien Hens, Gerben Menschaert, Geert Baggerman, Dirk Valkenborg, and Gokhan Ertaylan. 2019. “Beyond Genes : Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.” GENES 10 (9).
Vancouver
1.
Boonen K, Hens K, Menschaert G, Baggerman G, Valkenborg D, Ertaylan G. Beyond genes : re-identifiability of proteomic data and its implications for personalized medicine. GENES. 2019;10(9).
IEEE
[1]
K. Boonen, K. Hens, G. Menschaert, G. Baggerman, D. Valkenborg, and G. Ertaylan, “Beyond genes : re-identifiability of proteomic data and its implications for personalized medicine,” GENES, vol. 10, no. 9, 2019.
@article{8647103,
  abstract     = {The increasing availability of high throughput proteomics data provides us with opportunities as well as posing new ethical challenges regarding data privacy and re-identifiability of participants. Moreover, the fact that proteomics represents a level between the genotype and the phenotype further exacerbates the situation, introducing dilemmas related to publicly available data, anonymization, ownership of information and incidental findings. In this paper, we try to differentiate proteomics from genomics data and cover the ethical challenges related to proteomics data sharing. Finally, we give an overview of the proposed solutions and the outlook for future studies.},
  articleno    = {682},
  author       = {Boonen, Kurt and Hens, Kristien and Menschaert, Gerben and Baggerman, Geert and Valkenborg, Dirk and Ertaylan, Gokhan},
  issn         = {2073-4425},
  journal      = {GENES},
  keywords     = {proteomics,re-identifiability,privacy,genomics,data,personal medicine,VARIANT PEPTIDES,PROTEIN,IDENTIFICATION,PIPELINE,QUANTIFICATION,DISCOVERY,NEXTPROT,CANCER},
  language     = {eng},
  number       = {9},
  pages        = {13},
  title        = {Beyond genes : re-identifiability of proteomic data and its implications for personalized medicine},
  url          = {http://dx.doi.org/10.3390/genes10090682},
  volume       = {10},
  year         = {2019},
}

Altmetric
View in Altmetric
Web of Science
Times cited: